UpHealth, Inc. Expected to Post Q1 2022 Earnings of ($0.06) Per Share (NYSE:UPH)

UpHealth, Inc. (NYSE:UPHGet Rating) – Research analysts at Oppenheimer cut their Q1 2022 earnings per share estimates for shares of UpHealth in a research report issued to clients and investors on Monday, April 18th. Oppenheimer analyst M. Wiederhorn now expects that the company will post earnings of ($0.06) per share for the quarter, down from their previous forecast of ($0.05). Oppenheimer also issued estimates for UpHealth’s Q3 2022 earnings at ($0.02) EPS, Q4 2022 earnings at ($0.01) EPS, FY2022 earnings at ($0.14) EPS, FY2023 earnings at ($0.06) EPS and FY2024 earnings at $0.01 EPS.

Other equities research analysts also recently issued research reports about the company. Lake Street Capital downgraded UpHealth from a “buy” rating to a “hold” rating in a report on Thursday, March 31st. Zacks Investment Research upgraded UpHealth from a “sell” rating to a “hold” rating in a report on Wednesday. Finally, Northland Securities decreased their price objective on UpHealth from $10.50 to $4.50 and set an “outperform” rating for the company in a report on Thursday, March 31st. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $9.63.

Shares of UPH opened at $0.91 on Thursday. UpHealth has a 52-week low of $0.85 and a 52-week high of $10.72. The business’s 50 day moving average price is $1.80 and its two-hundred day moving average price is $2.17. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.12 and a quick ratio of 1.09.

Institutional investors have recently made changes to their positions in the stock. Penserra Capital Management LLC bought a new stake in UpHealth during the third quarter worth $34,000. Morgan Stanley bought a new stake in UpHealth during the second quarter worth $75,000. Schonfeld Strategic Advisors LLC bought a new stake in UpHealth during the fourth quarter worth $28,000. Visionary Wealth Advisors bought a new stake in UpHealth during the fourth quarter worth $28,000. Finally, Griffin Asset Management Inc. bought a new position in UpHealth in the 3rd quarter valued at $43,000. Institutional investors and hedge funds own 6.46% of the company’s stock.

About UpHealth (Get Rating)

UpHealth, Inc operates as a digital health services company. It provides patient-centric digital health platform and tech-enabled services to manage health and integrate care. The company's solutions include Syntranet Core Platform, an integrated care management platform; Global Telemedicine; MedQuest Digital Pharmacy, a full-service pharmacy that offers manufactured medication, custom compounded medications, nutraceuticals, lab testing, advocacy, education, etc.; and Behavioral Telehealth solutions.

Featured Articles

Earnings History and Estimates for UpHealth (NYSE:UPH)

Receive News & Ratings for UpHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UpHealth and related companies with MarketBeat.com's FREE daily email newsletter.